Bullboard - Stock Discussion Forum Immunitybio Inc IBRX

Healthcare Biotechnology

Immunitybio, Inc. is a vertically integrated, clinical-stage biotechnology company developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. Using its proprietary platforms that amplify both the innate and adaptive branches of the immune system, its advances therapies and vaccines to defeat urologic and other cancers, as well as... see more

Add To Watchlist

NDAQ:IBRX - Post Discussion

Immunitybio Inc > ImmunityBio Announces Positive Overall Survival Results of A

View:

Post by whytestocks on Apr 25, 2024 12:15am

ImmunityBio Announces Positive Overall Survival Results of A

News; $IBRX ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung CancerQUILT 3.055 trial completed and shows median overall survival almost double that of standard of care chemotherapy in 2 nd - and 3 rd -line non-small cell lung cancer (NSCLC) patients whose cancer did not respond to checkpoint inhibitors with or without chemotherapy Positive results se...IBRX - ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer

122